Detalles de la búsqueda
1.
[Not Available]. / Étude prospective randomisée évaluant un protocole de 2 biopsies ciblées par fusion IRM/TRUS en comparaison avec un protocole standard de 12 biopsies écho-guidées.
Prog Urol
; 25(13): 832-3, 2015 Nov.
Artículo
en Francés
| MEDLINE | ID: mdl-26544425
2.
Accuracy and repeatability of prostate volume measurements by transrectal ultrasound.
Prostate Cancer Prostatic Dis
; 5(4): 273-8, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12627211
3.
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.
Drugs Aging
; 10(2): 107-18, 1997 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-9061268
4.
Complications of invasive, urodynamic examinations and prostate biopsies in patients with benign prostatic hyperplasia.
Scand J Urol Nephrol Suppl
; 172: 95-8, 1995.
Artículo
en Inglés
| MEDLINE | ID: mdl-8578262
5.
Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome.
Scand J Urol Nephrol Suppl
; 179: 113-7, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8908676
6.
Abnormal venous drainage from the penis examined by dynamic cavernosography and surgically treated.
Scand J Urol Nephrol Suppl
; 110: 261-5, 1988.
Artículo
en Inglés
| MEDLINE | ID: mdl-3187421
7.
A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia.
J Urol
; 150(2 Pt 1): 359-64, 1993 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-7686981
8.
Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia.
Eur Urol
; 26(3): 219-26, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7528662
9.
Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients.
Eur Urol
; 21(4): 257-62, 1992.
Artículo
en Inglés
| MEDLINE | ID: mdl-1281101
10.
alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia.
J Urol
; 154(3): 923-34, 1995 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-7543612
11.
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.
Eur Urol
; 27(4): 274-9, 1995.
Artículo
en Inglés
| MEDLINE | ID: mdl-7544732
12.
A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.
J Urol
; 150(1): 90-4, 1993 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-7685428
13.
Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia.
Eur Urol
; 22(1): 9-13, 1992.
Artículo
en Inglés
| MEDLINE | ID: mdl-1385147
14.
Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
Urology
; 56(2): 261-5, 2000 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10925090
15.
Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia.
J Urol
; 152(2 Pt 1): 448-52, 1994 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-7516978
16.
[Timely screening routines for prostatic cancer by Norwegian physicians]. / Norske legers rutiner for opportunistisk screening for prostatakreft.
Tidsskr Nor Laegeforen
; 119(24): 3572-6, 1999 Oct 10.
Artículo
en Nor
| MEDLINE | ID: mdl-10563174
17.
Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH).
Prostate Cancer Prostatic Dis
; 4(3): 173-177, 2001.
Artículo
en Inglés
| MEDLINE | ID: mdl-12497037
18.
Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.
J Urol
; 154(1): 100-4, 1995 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-7539852
19.
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
Br J Urol
; 75(3): 335-40, 1995 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-7537602
20.
Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia.
Scand J Clin Lab Invest
; 56(4): 319-25, 1996 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-8837238